ACM
IDXX icon

Acrisure Capital Management’s Idexx Laboratories IDXX Stock Holding History

Acrisure Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-617
Closed -$309K – 114
2023
Q1 		$309K Buy
+617
New +$295K 0.31% 126

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Acrisure Capital Management's IDXX Position: Q2 2023 in Review

Acrisure Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 617 shares — an estimated $309K sold.

Acrisure Capital Management first reported a position in IDXX in Q1 2023 and held it in 1 quarter. The position peaked at $309K in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Acrisure Capital Management reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Acrisure Capital Management sold 617 Idexx Laboratories shares in Q2 2023, an estimated $309K.
  • Acrisure Capital Management first reported a position in Idexx Laboratories in Q1 2023 and held it in 1 quarter.
  • Acrisure Capital Management's Idexx Laboratories position peaked at $309K in Q1 2023.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Acrisure Capital Management's 13F filing for Q2 2023.